300003 Stock Overview
Lepu Medical Technology (Beijing) Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Lepu Medical Technology (Beijing) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.88 |
| 52 Week High | CN¥16.94 |
| 52 Week Low | CN¥9.01 |
| Beta | 0.082 |
| 1 Month Change | -0.084% |
| 3 Month Change | 22.10% |
| 1 Year Change | -24.52% |
| 3 Year Change | -47.89% |
| 5 Year Change | -64.09% |
| Change since IPO | -25.05% |
Recent News & Updates
Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return
Dec 03
Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly
Nov 15Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Oct 28Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump
Oct 18Recent updates
Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return
Dec 03Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly
Nov 15Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Oct 28Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump
Oct 18Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding
Sep 02News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat
Aug 31Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts
Aug 27Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively
Aug 16Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314
Jun 23Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly
May 31Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal
May 13Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet
Feb 28Shareholder Returns
| 300003 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -0.08% | -2.8% | -2.1% |
| 1Y | -24.5% | -10.4% | 9.8% |
Return vs Industry: 300003 underperformed the CN Medical Equipment industry which returned -10.4% over the past year.
Return vs Market: 300003 underperformed the CN Market which returned 9.8% over the past year.
Price Volatility
| 300003 volatility | |
|---|---|
| 300003 Average Weekly Movement | 9.9% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 300003 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300003's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 10,652 | Zhi Bin Zhang | www.lepumedical.com |
Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloons; and cardiovascular products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, fractional flow reserves, and accessories.
Lepu Medical Technology (Beijing) Co., Ltd. Fundamentals Summary
| 300003 fundamental statistics | |
|---|---|
| Market cap | CN¥21.90b |
| Earnings (TTM) | CN¥707.26m |
| Revenue (TTM) | CN¥6.51b |
31.0x
P/E Ratio3.4x
P/S RatioIs 300003 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300003 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.51b |
| Cost of Revenue | CN¥2.58b |
| Gross Profit | CN¥3.93b |
| Other Expenses | CN¥3.22b |
| Earnings | CN¥707.26m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 60.38% |
| Net Profit Margin | 10.87% |
| Debt/Equity Ratio | 31.9% |
How did 300003 perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield124%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 03:00 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lepu Medical Technology (Beijing) Co., Ltd. is covered by 26 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yuan Gao | China International Capital Corporation Limited |